Cite
HARVARD Citation
Samalin, E. et al. (2020). TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?. Lancet oncology. 21 (8), pp. 1002-1003. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Samalin, E. et al. (2020). TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?. Lancet oncology. 21 (8), pp. 1002-1003. [Online].